ConductScience.org, home

Paper · 39199682

Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation.

Hackner D and 6 others. Cancers (Basel), 2024. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation. Papers, record 39199682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199682

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hackner DDanilohttps://orcid.org/0000-0003-3161-5094
2Merkel SSusannehttps://orcid.org/0000-0003-2676-9486
3Weiß AAndreas
4Krautz CChristianhttps://orcid.org/0000-0002-2537-5824
5Weber GFGeorg Fhttps://orcid.org/0000-0003-1175-4505
6Grützmann RRobert
7Brunner MMaximilian

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,540,286Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions.Int J Mol Sci2019https://conductscience.org/library/papers/31540286PubMed
232,366,995Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis.Eur J Clin Nutr2020https://conductscience.org/library/papers/32366995PubMed
337,239,137Impact of Aspirin Intake on Postoperative Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma-A Single-Center Evaluation.Biomedicines2023https://conductscience.org/library/papers/37239137PubMed
425,431,369Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review.HPB (Oxford)2015https://conductscience.org/library/papers/25431369PubMed
532,782,024Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.BMC Cancer2020https://conductscience.org/library/papers/32782024PubMed
633,802,006The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/33802006PubMed
730,341,417Optimizing the outcomes of pancreatic cancer surgery.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/30341417PubMed
87,165,009Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol1982https://conductscience.org/library/papers/7165009PubMed
925,635,347A new initiative on precision medicine.N Engl J Med2015https://conductscience.org/library/papers/25635347PubMed
1034,511,190Precision Medicine and Pancreatic Cancer.Surg Oncol Clin N Am2021https://conductscience.org/library/papers/34511190PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42,588,591Integration of Preoperative Neutrophil-to-Lymphocyte Ratio into Machine Learning Models for Predicting Lymph Node Metastasis in CRC.Cancers (Basel)2026https://conductscience.org/library/papers/42588591PubMed
42,587,141Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-relevant outcomes in unresectable pancreatic ductal adenocarcinoma.Support Care Cancer2026https://conductscience.org/library/papers/42587141PubMed
42,512,376Inflammation-Based Hematological Indices (NLR, PLR, LMR) in Pancreatic Cancer: Implications for Laboratory Diagnostics and Clinical Interpretation.Cancers (Basel)2026https://conductscience.org/library/papers/42512376PubMed
42,226,668Dynamic Prognostic Nutritional Index With Circulating Tumor DNA Predicts Survival in Localized Pancreatic Ductal Adenocarcinoma.J Surg Oncol2026https://conductscience.org/library/papers/42226668PubMed
41,892,325ChemoNETosis in Cancer: A Comprehensive Review of Treatment-Induced NET Formation and Therapeutic Consequences.Cells2026https://conductscience.org/library/papers/41892325PubMed
41,827,717
Endoscopic Ultrasound-Guided Versus Percutaneous Transhepatic Biliary Drainage After Failed Endoscopic Retrograde Cholangiopancreatography in Malignant Biliary Obstruction: A Single-Center Retrospective Cohort.
Cancers (Basel)2026https://conductscience.org/library/papers/41827717PubMed
41,484,243Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic ductal adenocarcinoma.NPJ Digit Med2026https://conductscience.org/library/papers/41484243PubMed
41,212,253Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma.Eur Radiol2026https://conductscience.org/library/papers/41212253PubMed
40,665,634GPRC5A/CXCL8/NLRP3-mediated neutrophil extracellular traps drive gemcitabine-nab-paclitaxel resistance in pancreatic adenocarcinoma.Cancer Biol Med2025https://conductscience.org/library/papers/40665634PubMed
40,361,375
Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curative Surgery for Pancreatic Ductal Adenocarcinoma: A Cohort Study with External Validation.
Cancers (Basel)2025https://conductscience.org/library/papers/40361375PubMed

1 to 10 of 11

See all 11 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CRP1,401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39199682

GET https://conductscience.org/api/papers/v1/39199682/references?page=2